1. A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS‐mutant melanoma. (10th October 2019) Authors: Nagler, Adi; Vredevoogd, David W.; Alon, Michal; Cheng, Phil F.; Trabish, Sophie; Kalaora, Shelly; Arafeh, Rand; Goldin, Victoria; Levesque, Mitchell P.; Peeper, Daniel S.; Samuels, Yardena Journal: Pigment cell & melanoma research Issue: Volume 33:Number 2(2020) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipoconstruct surface topography grating size influences vascularization onset in the dorsal skinfold chamber model. (1st April 2020) Authors: McLuckie, Michelle; Robotti, Francesco; Sanchez-Macedo, Nadia; Enderlin, Dominik; Frese, Laura; Cheng, Phil F.; Levesque, Mitchell P.; Egaña, José T.; Poulikakos, Dimos; Ferrari, Aldo; Lindenblatt, Nicole Journal: Acta biomaterialia Issue: Volume 106(2020) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Medical bioinformatics in melanoma. Issue 2 (March 2018) Authors: Cheng, Phil F. Journal: Current opinion in oncology Issue: Volume 30:Issue 2(2018:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis. Issue 5 (October 2018) Authors: Häfliger, Esther M.; Ramelyte, Egle; Mangana, Joanna; Kunz, Michael; Kazakov, Dmitry V.; Dummer, Reinhard; Cheng, Phil F. Journal: Melanoma research Issue: Volume 28:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Issue 4 (August 2017) Authors: Mangana, Joanna; Cheng, Phil F.; Kaufmann, Corina; Amann, Valerie C.; Frauchiger, Anna L.; Stögner, Viola; Held, Ulrike; von Moos, Roger; Michielin, Olivier; Braun, Ralph P.; Levesque, Mitchell P.; Goldinger, Simone M.; Dummer, Reinhard Journal: Melanoma research Issue: Volume 27:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NRASQ61K melanoma tumor formation is reduced by p38‐MAPK14 activation in zebrafish models and NRAS‐mutated human melanoma cells. (24th September 2020) Authors: Banik, Ishani; Cheng, Phil F.; Dooley, Christopher M.; Travnickova, Jana; Merteroglu, Munise; Dummer, Reinhard; Patton, Elizabeth E.; Busch‐Nentwich, Elisabeth M.; Levesque, Mitchell P. Journal: Pigment cell & melanoma research Issue: Volume 34:Number 2(2021) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma. Issue 2 (March 2016) Authors: Paulitschke, Verena; Eichhoff, Ossia; Cheng, Phil F.; Levesque, Mitchell P.; Höller, Christoph Journal: Current opinion in oncology Issue: Volume 28:Issue 2(2016:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. (October 2021) Authors: Hilbers, Marie-Luise; Dimitriou, Florentia; Lau, Peter; Bhave, Prachi; McArthur, Grant A.; Zimmer, Lisa; Kudura, Ken; Gérard, Camille L.; Levesque, Mitchell P.; Michielin, Olivier; Dummer, Reinhard; Cheng, Phil F.; Mangana, Joanna Journal: European journal of cancer Issue: Volume 156(2021) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response. (May 2021) Authors: Dimitriou, Florentia; Zaremba, Anne; Allayous, Clara; Kähler, Katharina C.; Gerard, Camille L.; Festino, Lucia; Schäfer, Sarah; Toussaint, Frédéric; Heinzerling, Lucie; Hassel, Jessica C.; Ascierto, Paolo A.; Michielin, Olivier; Hauschild, Axel; Lebbe, Céleste; Livingstone, Elisabeth; Ramelyte, E... Journal: European journal of cancer Issue: Volume 149(2021) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The impact of the COVID‐19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. (3rd March 2023) Authors: Troesch, Alexander; Hoellwerth, Magdalena; Forchhammer, Stephan; Del Regno, Laura; Lodde, Georg; Turko, Patrick; Cheng, Phil F.; Levesque, Mitchell L.; Hadaschik, Eva; Livingstone, Elisabeth; Peris, Ketty; Flatz, Lukas; Koelblinger, Peter; Dummer, Reinhard; Dimitriou, Florentia Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 37:Number 5(2023) Page Start: 922 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗